Hunter Associates Investment Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-2,850
Closed -$222K 159
2017
Q2
$222K Hold
2,850
0.09% 152
2017
Q1
$232K Hold
2,850
0.1% 146
2016
Q4
$205K Hold
2,850
0.09% 152
2016
Q3
$221K Hold
2,850
0.09% 144
2016
Q2
$222K Hold
2,850
0.1% 140
2016
Q1
$234K Hold
2,850
0.11% 130
2015
Q4
$254K Hold
2,850
0.11% 125
2015
Q3
$219K Sell
2,850
-150
-5% -$12.5K 0.1% 130
2015
Q2
$251K Hold
3,000
0.1% 128
2015
Q1
$271K Hold
3,000
0.11% 124
2014
Q4
$242K Hold
3,000
0.09% 129
2014
Q3
$225K Sell
3,000
-1,000
-25% -$72.8K 0.09% 133
2014
Q2
$274K Hold
4,000
0.11% 125
2014
Q1
$280K Hold
4,000
0.11% 132
2013
Q4
$267K Hold
4,000
0.1% 137
2013
Q3
$209K Sell
4,000
-400
-9% -$20.3K 0.09% 143
2013
Q2
$208K Buy
+4,400
New +$201K 0.08% 162

Other funds holding CAH

Hunter Associates Investment Management's CAH Position: Q3 2017 in Review

Hunter Associates Investment Management sold out of Cardinal Health (CAH) in Q3 2017, closing a stake of 2,850 shares — an estimated $222K sold.

Hunter Associates Investment Management first reported a position in CAH in Q2 2013 and held it in 17 quarters. The position peaked at $280K in Q1 2014. 712 funds tracked by Wall St. Rank hold CAH as of Q3 2017.

  • Hunter Associates Investment Management reported no remaining Cardinal Health position as of Q3 2017 after selling out during the quarter.
  • Hunter Associates Investment Management sold 2,850 Cardinal Health shares in Q3 2017, an estimated $222K.
  • Hunter Associates Investment Management first reported a position in Cardinal Health in Q2 2013 and held it in 17 quarters.
  • Hunter Associates Investment Management's Cardinal Health position peaked at $280K in Q1 2014.
  • 712 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2017.

Based on Hunter Associates Investment Management's 13F filing for Q3 2017, filed 13 Nov 2017.